Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dräger Antigen Test SARS-CoV-2 Clinical Performance Study

NCT04698993 is registered in ClinicalTrials.gov with Drägerwerk AG & Co. KGaA as lead sponsor.

NCT NCT04698993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04698993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dräger Antigen Test SARS-CoV-2 Clinical Performance Study
Lead sponsor
Drägerwerk AG & Co. KGaA
Phase
Not applicable
Overall status
Terminated
Start date
February 12, 2021
Completion date
March 22, 2021
Enrollment
388 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19